Annual Long Term Liabilities:
$630.00K-$306.00K(-32.69%)Summary
- As of today, VKTX annual total long term liabilities is $630.00 thousand, with the most recent change of -$306.00 thousand (-32.69%) on December 31, 2024.
- During the last 3 years, VKTX annual long term liabilities has risen by +$630.00 thousand (+100.00%).
- VKTX annual long term liabilities is now -86.70% below its all-time high of $4.74 million, reached on December 31, 2015.
Performance
VKTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Long Term Liabilities:
$318.00K-$92.00K(-22.44%)Summary
- As of today, VKTX quarterly total long term liabilities is $318.00 thousand, with the most recent change of -$92.00 thousand (-22.44%) on September 30, 2025.
- Over the past year, VKTX quarterly long term liabilities has dropped by -$437.00 thousand (-57.88%).
- VKTX quarterly long term liabilities is now -93.73% below its all-time high of $5.07 million, reached on March 31, 2016.
Performance
VKTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
VKTX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -32.7% | -57.9% |
| 3Y3 Years | +100.0% | -76.2% |
| 5Y5 Years | +75.0% | +176.5% |
VKTX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -50.0% | >+9999.0% | -76.2% | at low |
| 5Y | 5-Year | -50.0% | >+9999.0% | -78.7% | >+9999.0% |
| All-Time | All-Time | -86.7% | >+9999.0% | -93.7% | >+9999.0% |
VKTX Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $318.00K(-22.4%) |
| Jun 2025 | - | $410.00K(-18.3%) |
| Mar 2025 | - | $502.00K(-20.3%) |
| Dec 2024 | $630.00K(-32.7%) | $630.00K(-16.6%) |
| Sep 2024 | - | $755.00K(-1.4%) |
| Jun 2024 | - | $766.00K(-10.1%) |
| Mar 2024 | - | $852.00K(-9.0%) |
| Dec 2023 | $936.00K(-25.7%) | $936.00K(-8.1%) |
| Sep 2023 | - | $1.02M(-7.5%) |
| Jun 2023 | - | $1.10M(-6.9%) |
| Mar 2023 | - | $1.18M(-6.3%) |
| Dec 2022 | $1.26M(>+9900.0%) | $1.26M(-5.8%) |
| Sep 2022 | - | $1.34M(-5.4%) |
| Jun 2022 | - | $1.41M(-5.1%) |
| Mar 2022 | - | $1.49M(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2021 | - | $0.00(0.0%) |
| Jun 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $29.00K(-91.9%) | $29.00K(-74.8%) |
| Sep 2020 | - | $115.00K(-41.9%) |
| Jun 2020 | - | $198.00K(-29.0%) |
| Mar 2020 | - | $279.00K(-22.5%) |
| Dec 2019 | $360.00K | $360.00K(-17.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $438.00K(-14.6%) |
| Jun 2019 | - | $513.00K(-12.8%) |
| Mar 2019 | - | $588.00K(+4800.0%) |
| Dec 2018 | $12.00K(>+9900.0%) | $12.00K(>+9900.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(-100.0%) |
| Jun 2017 | - | $6100.00(-99.9%) |
| Mar 2017 | - | $4.22M(>+9900.0%) |
| Dec 2016 | $16.30K(-99.7%) | $16.30K(-20.5%) |
| Sep 2016 | - | $20.50K(-16.7%) |
| Jun 2016 | - | $24.60K(-99.5%) |
| Mar 2016 | - | $5.07M(+7.0%) |
| Dec 2015 | $4.74M(+78.5%) | $4.74M(>+9900.0%) |
| Sep 2015 | - | $19.10K(>+9900.0%) |
| Jun 2015 | - | $0.00(-100.0%) |
| Mar 2015 | - | $2.90M(+122.4%) |
| Dec 2014 | $2.65M(+774.7%) | - |
| Jun 2014 | - | $1.30M(+308.5%) |
| Mar 2014 | - | $319.10K |
| Dec 2013 | $303.50K(+495.1%) | - |
| Dec 2012 | $51.00K | - |
FAQ
- What is Viking Therapeutics, Inc. annual total long term liabilities?
- What is the all-time high annual long term liabilities for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. annual long term liabilities year-on-year change?
- What is Viking Therapeutics, Inc. quarterly total long term liabilities?
- What is the all-time high quarterly long term liabilities for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. quarterly long term liabilities year-on-year change?
What is Viking Therapeutics, Inc. annual total long term liabilities?
The current annual long term liabilities of VKTX is $630.00K
What is the all-time high annual long term liabilities for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high annual total long term liabilities is $4.74M
What is Viking Therapeutics, Inc. annual long term liabilities year-on-year change?
Over the past year, VKTX annual total long term liabilities has changed by -$306.00K (-32.69%)
What is Viking Therapeutics, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of VKTX is $318.00K
What is the all-time high quarterly long term liabilities for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high quarterly total long term liabilities is $5.07M
What is Viking Therapeutics, Inc. quarterly long term liabilities year-on-year change?
Over the past year, VKTX quarterly total long term liabilities has changed by -$437.00K (-57.88%)